| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 0.0003 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0005 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0005 |